Showing 1 - 5 results of 5 for search 'Marc Bourlière', query time: 0.04s Refine Results
  1. 1
    Prevalence and characterization of NS5A resistance associated variants (RAVs) in patients who relapsed following exposure to NS5A inhibitors

    Prevalence and characterization of NS5A resistance associated variants (RAVs) in patients who relapsed following exposure to NS5A inhibitors by Guillaume Penaranda, Philippe Halfon, Caroline Scholtès, Sofiane Mohamed, Vincent Leroy, Marc Bourlière, Denis Ouzan, Guillaume Pénaranda, Hacène Khiri, Laura Polverel, Fabien Zoulim, Marie-Ange Thélu, Sylvie Larrat

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir

    HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir by Harel Dahari, Laetitia Canini, Frederik Graw, Susan L. Uprichard, EvaldoS A. Araujo, Guillaume Penaranda, Emilie Coquet, Aurélie Riso, Christophe Renou, Marc Bourlière, Scott J. Cotler, Philippe Halfon

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort)

    Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort) by Tangui Barré, Hélène Fontaine, Stanislas Pol, Clémence Ramier, Vincent Di Beo, Camelia Protopopescu, Fabienne Marcellin, Morgane Bureau, Marc Bourlière, Céline Dorival, Ventzislava Petrov-Sanchez, Tarik Asselah, Elisabeth Delarocque-Astagneau, Dominique Larrey, Jean-Charles, Fabrice Carrat, Patrizia Carrieri, on behalf of the ANRS/AFEF Hepather Study Group

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Multidisciplinary approach for the treatment of 1155 HCV/HCV-HIV co-infected patients

    Multidisciplinary approach for the treatment of 1155 HCV/HCV-HIV co-infected patients by Isabelle Ravaux, Albert Darque, Amélie Ménard, Catherine Dhiver, Philippe Halfon, Thierry Allègre, Patrick Philibert, Christelle Tomei, Philippe Colson, Rolande Cohen, Laurence Pellissier, Sylvie Brégigeon, Malika Mokhtari, Jacques Moreau, Marie-Josephe Soavi, Caroline Solas, Isabelle Poizot-Martin, Bernard Castan, Valérie Oulès, Marc Bourlière, Isabelle Portal, Danielle Botta-Fridlund

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    P16 SOF/VEL/VOX for 8 or 12 weeks results in high SVR12 rates: an integrated analysis of the POLARIS-1, POLARIS-2, POLARIS-3 AND POLARIS-4 studies

    P16 SOF/VEL/VOX for 8 or 12 weeks results in high SVR12 rates: an integrated analysis of the POLARIS-1, POLARIS-2, POLARIS-3 AND POLARIS-4 studies by Stuart K. Roberts, Curtis L. Cooper, Eric Lawitz, K. Rajender Reddy, Alex J. Thompson, Stefan Zeuzem, Ira M. Jacobson, Peter Ruane, Robert H. Hyland, Luisa M. Stamm, Lingling Han, Diana M. Brainard, Norbert Bräu, Tarik Asselah, Bernard E. Willems, Steven Flamm, Marc Bourlière, Graham R. Foster, Edward J. Gane, Michael Manns, Stuart C. Gordon, Kris Kowdley

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: